• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种使用自固化生物活性玻璃骨水泥的新型骨骼药物递送系统。IV:头孢氨苄从含聚合物包衣块状粉末的骨水泥中的释放。

A novel skeletal drug delivery system using self-setting bioactive glass bone cement. IV: Cephalexin release from cement containing polymer-coated bulk powder.

作者信息

Otsuka M, Matsuda Y, Kokubo T, Yoshihara S, Nakamura T, Yamamuro T

机构信息

Department of Pharmaceutical Technology, Kobe Pharmaceutical University, Japan.

出版信息

Biomed Mater Eng. 1993 Winter;3(4):229-36.

PMID:8205064
Abstract

A novel device consisting of Eudragit-coated cephalexin as a model drug and a self-setting bioactive cement based upon CaO-SiO2-P2O5 glass was investigated. The glass cement hardened within 5 min of mixing with a phosphate buffer. After setting, in vitro drug release from homogeneous or heterogeneous drug-loaded cement pellets in a simulated body fluid (SBF) at pH 7.25 and 37 degrees C continued for over 2 weeks. The hardened cement gradually formed low-crystallinity hydroxyapatite and decreased in volume by about 5% during drug release in SBF. Consequently, 30% of the loaded drug was initially released from the homogeneous cement system, and thereafter it was released more slowly. Since the heterogeneous system consisting of the cement and a 50% polymer coated, drug-loaded pellet avoided this drug's burst, the drug was released over a longer period than that in the homogeneous system. The heterogeneous system released the polymer-coated drug very slowly, because it completely avoided the initial burst, and sustained the release over a long period.

摘要

研究了一种新型装置,该装置由作为模型药物的丙烯酸树脂包衣头孢氨苄和基于CaO-SiO₂-P₂O₅玻璃的自固化生物活性水泥组成。玻璃水泥与磷酸盐缓冲液混合后5分钟内硬化。固化后,在pH 7.25和37℃的模拟体液(SBF)中,均匀或非均匀载药水泥微丸的体外药物释放持续超过2周。在SBF中药物释放过程中,硬化水泥逐渐形成低结晶度羟基磷灰石,体积减少约5%。因此,30%的载药最初从均匀水泥体系中释放,此后释放速度更慢。由于由水泥和50%聚合物包衣的载药微丸组成的非均匀体系避免了这种药物的突释,药物释放时间比均匀体系更长。非均匀体系非常缓慢地释放聚合物包衣药物,因为它完全避免了初始突释,并能长期维持释放。

相似文献

1
A novel skeletal drug delivery system using self-setting bioactive glass bone cement. IV: Cephalexin release from cement containing polymer-coated bulk powder.一种使用自固化生物活性玻璃骨水泥的新型骨骼药物递送系统。IV:头孢氨苄从含聚合物包衣块状粉末的骨水泥中的释放。
Biomed Mater Eng. 1993 Winter;3(4):229-36.
2
Drug release from a novel self-setting bioactive glass bone cement containing cephalexin and its physicochemical properties.含头孢氨苄的新型自固化生物活性玻璃骨水泥的药物释放及其理化性质。
J Biomed Mater Res. 1995 Jan;29(1):33-8. doi: 10.1002/jbm.820290106.
3
The in vitro and in vivo indomethacin release from self-setting bioactive glass bone cement.自固化生物活性玻璃骨水泥中吲哚美辛的体外和体内释放
Biomed Mater Eng. 1997;7(5):291-302.
4
Bone bonding ability of bioactive bone cements.生物活性骨水泥的骨结合能力。
Clin Orthop Relat Res. 1997 Oct(343):183-91.
5
Antibiotic delivery system using nano-hydroxyapatite/chitosan bone cement consisting of berberine.使用由黄连素组成的纳米羟基磷灰石/壳聚糖骨水泥的抗生素递送系统。
J Biomed Mater Res A. 2009 Jun 15;89(4):1108-17. doi: 10.1002/jbm.a.32199.
6
Novel bioactive and biodegradable glass ceramics with high mechanical strength in the CaO--SiO2--B2O3 system.CaO-SiO₂-B₂O₃体系中具有高机械强度的新型生物活性和可生物降解玻璃陶瓷。
J Biomed Mater Res A. 2004 Jan 1;68(1):79-89. doi: 10.1002/jbm.a.20029.
7
Effects of ceramic component on cephalexin release from bioactive bone cement consisting of Bis-GMA/TEGDMA resin and bioactive glass ceramics.陶瓷成分对由双酚A-双甲基丙烯酸缩水甘油酯/三乙二醇二甲基丙烯酸酯树脂和生物活性玻璃陶瓷组成的生物活性骨水泥中头孢氨苄释放的影响。
Biomed Mater Eng. 2001;11(1):11-22.
8
Formation of hydroxyapatite onto glasses of the CaO-MgO-SiO2 system with B2O3, Na2O, CaF2 and P2O5 additives.在添加了B2O3、Na2O、CaF2和P2O5的CaO-MgO-SiO2系统玻璃上形成羟基磷灰石。
Biomaterials. 2006 Mar;27(9):1832-40. doi: 10.1016/j.biomaterials.2005.10.033. Epub 2005 Nov 23.
9
Hydroxyapatite/SiO(2)-CaO-P(2)O(5) glass materials: in vitro bioactivity and biocompatibility.羟基磷灰石/SiO(2)-CaO-P(2)O(5)玻璃材料:体外生物活性和生物相容性
Acta Biomater. 2006 May;2(3):331-42. doi: 10.1016/j.actbio.2006.01.006. Epub 2006 Mar 24.
10
Bioactive hydroxyapatite coatings on polymer composites for orthopedic implants.用于骨科植入物的聚合物复合材料上的生物活性羟基磷灰石涂层
J Biomed Mater Res A. 2005 Jun 15;73(4):398-408. doi: 10.1002/jbm.a.30284.